JAXBIO Technologies
JaxBio is a biomedical company developing a simple, fast, and cost-effective blood test for early cancer diagnosis. Their proprietary technology detects unique genetic and epigenetic markers in cell-free DNA from blood samples, enabling identification of cancer type and stage with high sensitivity. Utilizing AI algorithms, JaxBio defines biomarker panels for various cancers, currently focusing on lung cancer and hematological malignancies. The company aims to improve cancer detection, monitoring, and therapy response prediction, supported by significant grants such as the European Innovation Council Accelerator and Horizon Europe Cancer Mission. Their team comprises experts in cancer biology, genomics, chemistry, bioinformatics, and machine learning, positioning JaxBio as an innovative player in cancer diagnostics.
JAXBIO Technologies
JaxBio is a biomedical company developing a simple, fast, and cost-effective blood test for early cancer diagnosis. Their proprietary technology detects unique genetic and epigenetic markers in cell-free DNA from blood samples, enabling identification of cancer type and stage with high sensitivity. Utilizing AI algorithms, JaxBio defines biomarker panels for various cancers, currently focusing on lung cancer and hematological malignancies. The company aims to improve cancer detection, monitoring, and therapy response prediction, supported by significant grants such as the European Innovation Council Accelerator and Horizon Europe Cancer Mission. Their team comprises experts in cancer biology, genomics, chemistry, bioinformatics, and machine learning, positioning JaxBio as an innovative player in cancer diagnostics.